149 related articles for article (PubMed ID: 30840280)
1. MiRNA-106a promotes breast cancer progression by regulating DAX-1.
Liu C; Song YH; Mao Y; Wang HB; Nie G
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1574-1583. PubMed ID: 30840280
[TBL] [Abstract][Full Text] [Related]
2. LncRNA SNHG7 promotes development of breast cancer by regulating microRNA-186.
Luo X; Song Y; Tang L; Sun DH; Ji DG
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(22):7788-7797. PubMed ID: 30536320
[TBL] [Abstract][Full Text] [Related]
3. MicroRNA-374b inhibits migration and invasion of glioma cells by targeting EGFR.
Pan DS; Cao P; Li JJ; Fan D; Song ZQ
Eur Rev Med Pharmacol Sci; 2019 May; 23(10):4254-4263. PubMed ID: 31173297
[TBL] [Abstract][Full Text] [Related]
4. CircRNA_100876 promote proliferation and metastasis of breast cancer cells through adsorbing microRNA-361-3p in a sponge form.
Yang CY; Zhang FX; He JN; Wang SQ
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6962-6970. PubMed ID: 31486496
[TBL] [Abstract][Full Text] [Related]
5. CD151 promotes breast cancer metastasis by activating TGF-β1/Smad signaling pathway.
Zhao SJ; Zhao HD; Li J; Zhang H; Gao DT; Wang Q
Eur Rev Med Pharmacol Sci; 2018 Nov; 22(21):7314-7322. PubMed ID: 30468476
[TBL] [Abstract][Full Text] [Related]
6. MicroRNA-548c-5p inhibits the proliferation of breast cancer cells through regulating Wnt/β-catenin signaling pathway.
He SZ; Wang Q
Eur Rev Med Pharmacol Sci; 2020 Apr; 24(7):3795-3804. PubMed ID: 32329856
[TBL] [Abstract][Full Text] [Related]
7. MicroRNA-487a promotes proliferation of esophageal cancer cells by inhibiting p62 expression.
Ma JB; Hu SL; Zang RK; Su Y; Liang YC; Wang Y
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1502-1512. PubMed ID: 30840272
[TBL] [Abstract][Full Text] [Related]
8. Downregulated lncRNA ADAMTS9-AS2 in breast cancer enhances tamoxifen resistance by activating microRNA-130a-5p.
Shi YF; Lu H; Wang HB
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1563-1573. PubMed ID: 30840279
[TBL] [Abstract][Full Text] [Related]
9. MiR-566 protects the malignant progression of breast cancer by negatively regulating WNT6.
Zhao MC; Zhang MM; Li T; Tao ZH; Du YQ; Wang LP; Zhang J; Wang BY; Hu XC
Eur Rev Med Pharmacol Sci; 2020 Jun; 24(11):6185-6194. PubMed ID: 32572884
[TBL] [Abstract][Full Text] [Related]
10. MicroRNA-330-5p promotes the development of osteosarcoma by regulating SPRY2.
Wei Q; Li QQ; Zhai XC; Qin L; Li HB; Meng R; Han XF
Eur Rev Med Pharmacol Sci; 2019 Oct; 23(20):8761-8770. PubMed ID: 31696462
[TBL] [Abstract][Full Text] [Related]
11. MicroRNA-129-5p inhibits invasiveness and metastasis of lung cancer cells and tumor angiogenesis via targeting VEGF.
Cheng XK; Lin WR; Jiang H; Su ZH; Li L; Wang J
Eur Rev Med Pharmacol Sci; 2019 Apr; 23(7):2827-2837. PubMed ID: 31002164
[TBL] [Abstract][Full Text] [Related]
12. MiR-491 suppresses migration and invasion via directly targeting TPX2 in breast cancer.
Tan GZ; Li M; Tan X; Shi ML; Mou K
Eur Rev Med Pharmacol Sci; 2019 Nov; 23(22):9996-10004. PubMed ID: 31799669
[TBL] [Abstract][Full Text] [Related]
13. MiRNA-221-5p promotes breast cancer progression by regulating E-cadherin expression.
Niu XY; Zhang ZQ; Ma PL
Eur Rev Med Pharmacol Sci; 2019 Aug; 23(16):6983-6990. PubMed ID: 31486498
[TBL] [Abstract][Full Text] [Related]
14. MicroRNA-625-3p inhibits gastric cancer metastasis through modulating EZH2.
Li Y; Zhou HC; Zhang Y; Huang H
Eur Rev Med Pharmacol Sci; 2020 Feb; 24(3):1177-1185. PubMed ID: 32096165
[TBL] [Abstract][Full Text] [Related]
15. MicroRNA-1269a promotes the occurrence and progression of osteosarcoma by inhibit-ing TGF-β1 expression.
Yu SN; Miao YY; Zhang BT; Dai YM; Liu L; Gao ZL; Liu GF
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(3):972-981. PubMed ID: 30779063
[TBL] [Abstract][Full Text] [Related]
16. miRNA-217 inhibits proliferation of hepatocellular carcinoma cells by regulating KLF5.
Gao W; Lu YX; Wang F; Sun J; Bian JX; Wu HY
Eur Rev Med Pharmacol Sci; 2019 Sep; 23(18):7874-7883. PubMed ID: 31599412
[TBL] [Abstract][Full Text] [Related]
17. MicroRNA-203 promotes the progression of non-small cell lung cancer via surviving.
Wang T; Li W; Li W; Liu L; Zhang H
J BUON; 2019; 24(2):591-598. PubMed ID: 31128011
[TBL] [Abstract][Full Text] [Related]
18. LncRNA LINP1 promotes malignant progression of pancreatic cancer by adsorbing microRNA-491-3p.
Chen AY; Zhang K; Liu GQ
Eur Rev Med Pharmacol Sci; 2020 Sep; 24(18):9315-9324. PubMed ID: 33015772
[TBL] [Abstract][Full Text] [Related]
19. In vivo and in vitro effects of microRNA-27a on proliferation, migration and invasion of breast cancer cells through targeting of SFRP1 gene via Wnt/β-catenin signaling pathway.
Kong LY; Xue M; Zhang QC; Su CF
Oncotarget; 2017 Feb; 8(9):15507-15519. PubMed ID: 28099945
[TBL] [Abstract][Full Text] [Related]
20. LncRNA HOTAIR promotes colon cancer development by down-regulating miRNA-34a.
Peng CL; Zhao XJ; Wei CC; Wu JW
Eur Rev Med Pharmacol Sci; 2019 Jul; 23(13):5752-5761. PubMed ID: 31298326
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]